PROTAC as a Potential Toolbox for the Discovery of New Targets and Drugs
PROTAC technology evolves from a basic tool into a full platform for discovering new drug targets and developing precision medicines.
With its event-driven degradation mechanism, proteolysis targeting chimera (PROTAC) is emerging as a powerful toolbox for novel drug discovery and target identification. The reported conclusion is: PROTAC technology has evolved from a mere intervention tool to an integrated platform for new target and drug discovery, providing transformative strategies for precision medicine and innovative drug development.
What the study was
- Study design
- Validation study
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Handbook of experimental pharmacology
Why it surfaced
Retained for Precision oncology and genomic medicine; score reflects the available PubMed abstract, study design, clinical relevance, and unmet need.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.